It could just be that the Nasdaq wants clarification on something. In the case of exchange listed stocks, the exchange deals with problems like these; the SEC only suspends OTC issues.
But if you're thinking of NEWL, its T12 is a bad thing. The company's drowning in toxic conversions and sales. Two reverse splits in the second half of 2013; three so far this year. I think Nasdaq has had enough of NEWL.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.